BD Pharmingen- PE Mouse Anti-Human MIP-1_BD Pharmingen
参考图片
Expression of MIP-1β by stimulated human monocytes. Human PBMC were stimulated with human IFN-γ (20 ng/ml final concentration; Cat. No. 554616/554617) for one hour followed by overnight stimulation with LPS (1 µg/ml final concentration; Sigma, Cat. No. L-8272) in the presence of GolgiStop™ (2 µM final concentration; Cat. No. 554724). The PBMC were harvested, fixed, permeabilized, and stained with 0.03 µg of PE Mouse Anti-Human MIP-1β (Cat. 550078/561120; Left Panel) following Pharmingen's staining protocol. The data reflects gating on monocytes, based on forward and side scattered light signals. To demonstrate specificity of staining, binding by the PE Mouse Anti-Human MIP-1β antibody was blocked by preincubation with recombinant human MIP-1β (0.25 µg; Middle panel) and by preincubation of the fixed/permeabilized cells with excess unlabeled D21- 1351 antibody (5 µg; custom order; Right panel) prior to staining with PE Mouse Anti-Human MIP-1β. The quadrant markers for the bivariate dot plots were set based on the autofluorescence control and verified using the unlabeled antibody blocking control.
本文来自投稿,不代表本人立场,如若转载,请注明出处:http://www.iamyjet.com/kangti/8602.html